(Q46192229)

English

Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

author name string

Wataru Arai

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Yoshinori Hosoya

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Hidenori Haruta

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Kentaro Kurashina

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Shin Saito

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Yuuki Hirashima

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Taku Yokoyama

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Toru Zuiki

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Kazuya Sakuma

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Masanobu Hyodo

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Yoshikazu Yasuda

11

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Hideo Nagai

12

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Tetsuhiko Shirasaka

13

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

publication date

18 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

13

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

515-520

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

https://scigraph.springernature.com/pub.10.1007/s10147-008-0780-4

0 references

Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of human tumor xenografts in genetically athymic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternate-day oral therapy with TS-1 for advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conceptual changes in cancer chemotherapy: from an oral fluoropyrimidine prodrug, UFT, to a novel oral fluoropyrimidine prodrug, S-1, and low-dose FP therapy in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined effects of S-1, a new form of oral tegafur, plus modulators on ovarian cancer in nude rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of proliferation of cancer cells in neoplastic effusions in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S-1 in gastric cancer: a comprehensive review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Japanese nationwide post-marketing survey of S-1 in patients with advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[An experimental study of anticancer agent sensitivity test in human gastric cancer cell lines by flow cytometry]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferating cell nuclear antigen as a predictor of therapeutic effect of continuous 5-fluorouracil administration in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU from bench to clinic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. II. CELL RENEWAL IN STOMACH, ILEUM, COLON, AND RECTUM

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of type 4 gastric cancer with peritoneal dissemination successfully treated over 2 years by alternate-day administration of TS-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/19093179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-008-0780-4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19093179

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46192229&oldid=2099053945"